{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:15:30Z","timestamp":1762658130953},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[1997,4,1]],"date-time":"1997-04-01T00:00:00Z","timestamp":859852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T00:00:00Z","timestamp":1577404800000},"content-version":"vor","delay-in-days":8305,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[1997,4]]},"DOI":"10.1023\/a:1008249232000","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T13:47:34Z","timestamp":1040564854000},"page":"363-367","source":"Crossref","is-referenced-by-count":20,"title":["Phase II trial of tirapazamine combined with cisplatin in chemotherapy of advanced malignant melanoma"],"prefix":"10.1016","volume":"8","author":[{"given":"A.Y.","family":"Bedikian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.S.","family":"Legha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Eton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.C.","family":"Buzaid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Papadopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Coates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Neefe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"von Roemeling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1023\/A:1008249232000_bb0060","first-page":"34","article-title":"Current therapy for malignant melanoma","volume":"16","author":"Legha","year":"1989","journal-title":"Semin Oncol"},{"key":"10.1023\/A:1008249232000_bb0065","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/1097-0142(197502)35:2<342::AID-CNCR2820350207>3.0.CO;2-F","article-title":"Combination chemotherapy for disseminated malignant melanoma","volume":"35","author":"Costanzi","year":"1975","journal-title":"Cancer"},{"key":"10.1023\/A:1008249232000_bb0070","first-page":"821","article-title":"Cisplatin, vinblastine, and bleomycin in the treatment of metastatic melanoma. A phase II study of the Southeastern Cancer Study Group","volume":"69","author":"Johnson","year":"1985","journal-title":"Cancer Treat Rep"},{"key":"10.1023\/A:1008249232000_bb0075","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1002\/1097-0142(19891115)64:10<2024::AID-CNCR2820641010>3.0.CO;2-V","article-title":"A prospective evaluation of a triple-drug regimen containing cisplatin, vinblastine, and dacarbazine (CVD) for metastatic melanoma","volume":"64","author":"Legha","year":"1989","journal-title":"Cancer"},{"key":"10.1023\/A:1008249232000_bb0080","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/ijc.2910500410","article-title":"Effective combination chemo\/hormonal therapy for malignant melanoma: Experience with three consecutive trials","volume":"50","author":"McClay","year":"1992","journal-title":"Int J Cancer"},{"key":"10.1023\/A:1008249232000_bb0085","first-page":"5947","article-title":"Metabolism of SR 4233 by Chinese hamster ovary cells: Basis of selective hypoxic cytotoxiciy","volume":"48","author":"Baker","year":"1988","journal-title":"Cancer Res"},{"key":"10.1023\/A:1008249232000_bb0090","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/carcin\/11.8.1407","article-title":"Reductive metabolism of 3-amino-l,2,4,-benzotriazine-1,4-dioxide (SR 4233) and the induction of unscheduled DNA synthesis in rat and human derived cell lines","volume":"11","author":"Cahill","year":"1990","journal-title":"Carcinogenesis"},{"key":"10.1023\/A:1008249232000_bb0095","first-page":"4633","article-title":"Tumor-specific, schedule-dependent interaction between tirapazamine (SR 4233) and cisplatin","volume":"53","author":"Done","year":"1993","journal-title":"Cancer Res"},{"key":"10.1023\/A:1008249232000_bb0100","first-page":"37","article-title":"A phase II study with high-dose cis-DDP Wadley","volume":"6","author":"Chary","year":"1976","journal-title":"Med Bull"},{"key":"10.1023\/A:1008249232000_bb0105","first-page":"2005","article-title":"Cis-dichlorodiammineplatinum (II) alone and combined with DTIC for treatment of disseminated malignant melanoma","volume":"63","author":"Goodnight","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"10.1023\/A:1008249232000_bb0110","first-page":"31","article-title":"Cisplatin hydration with and without mannitol diuresis in refractory disseminated malignant melanoma","volume":"66","author":"Al-Sarraf","year":"1982","journal-title":"Cancer Treat Rep"},{"key":"10.1023\/A:1008249232000_bb0115","first-page":"120","article-title":"Experiences with high-dose cisplatin therapy in metastasized malignant melanoma","volume":"5","author":"Voigt","year":"1982","journal-title":"Onkologie"},{"key":"10.1023\/A:1008249232000_bb0120","first-page":"371","article-title":"Cis-diamminedichloroplatinum in the treatment of disseminated malignant melanoma","volume":"30","author":"Mechl","year":"1983","journal-title":"Neoplasma"},{"key":"10.1023\/A:1008249232000_bb0125","first-page":"254","article-title":"High dose cisplatin in metastatic melanoma: Comparison of two schedules","volume":"7","author":"Mortimer","year":"1988","journal-title":"FTOC Am Soc Clin Oncol"},{"key":"10.1023\/A:1008249232000_bb0130","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/BF00686241","article-title":"High-dose cisplatin in disseminated malanoma: A comparison of two schedules","volume":"25","author":"Mortimer","year":"1990","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1023\/A:1008249232000_bb0135","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0360-3016(89)90283-6","article-title":"Clinical trials of WR-2721 and cisplatinum","volume":"16","author":"Glover","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1023\/A:1008249232000_bb0140","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/1097-0142(19910915)68:6<1238::AID-CNCR2820680609>3.0.CO;2-#","article-title":"High-dose cisplatin with dacarbazine and tamoxifen in the treatment of metastatic melanoma","volume":"68","author":"Buzaid","year":"1991","journal-title":"Cancer"},{"key":"10.1023\/A:1008249232000_bb0145","first-page":"344","article-title":"High-dose cisplatin (C) and WR 2721 in metastatic melanoma","volume":"11","author":"Avril","year":"1992","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1023\/A:1008249232000_bb0150","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/1097-0142(19880915)62:6<1061::AID-CNCR2820620607>3.0.CO;2-X","article-title":"Combination of cisplatin, vindesine, and dacarbazine in advanced malignant melanoma: A phase II study of the EORTC malignant melanoma cooperative group","volume":"62","author":"Verschraegen","year":"1988","journal-title":"Cancer"},{"key":"10.1023\/A:1008249232000_bb0155","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF00177256","article-title":"Phase II trial of carboplatm in advanced malignant melanoma","volume":"8","author":"Casper","year":"1990","journal-title":"Invest New Drugs"},{"key":"10.1023\/A:1008249232000_bb0160","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/00000421-199304000-00015","article-title":"Phase II trial of carboplatin in patients with metastatic malignant melanoma. A report from the Eastern Cooperative Oncology Group","volume":"16","author":"Chang","year":"1993","journal-title":"Am J Clin Oncol"},{"key":"10.1023\/A:1008249232000_bb0165","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/jnci\/84.3.187","article-title":"Re-enhancement of alkylating agent activity by SR-4233 in the FsaII C murine fibrosarcoma","volume":"84","author":"Holden","year":"1992","journal-title":"J Natl Cancer Inst"},{"key":"10.1023\/A:1008249232000_bb0170","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1002\/1097-0142(19951101)76:9<1665::AID-CNCR2820760925>3.0.CO;2-J","article-title":"Treatment of uveal melanoma metastatic to the liver. A review of the M.D Anderson Cancer Center experience and prognostic factors","volume":"76","author":"Bedikian","year":"1995","journal-title":"Cancer"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419605405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419605405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/8\/4\/363\/19480804\/8-4-363.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T01:03:14Z","timestamp":1582246994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419605405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,4]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1997,4]]}},"alternative-id":["S0923753419605405"],"URL":"https:\/\/doi.org\/10.1023\/a:1008249232000","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[1997,4]]}}}